DeDora Capital’s AstraZeneca AZN Stock Holding History

DeDora Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$422K	Sell	2,226 -7	-0.3%	-$1.32K	0.09%	91
2026 Q1	$440K	Buy	2,233 +4	+0.2%	+$771	0.11%	84
2025 Q4	$410K	Buy	2,229 +78	+4%	+$13.7K	0.1%	89
2025 Q3	$330K	Hold	2,151	–	–	0.08%	101
2025 Q2	$301K	Buy	2,151 +150	+7%	+$21K	0.08%	102
2025 Q1	$294K	Buy	+2,001	New	+$290K	0.08%	100
2022 Q2	–	Sell	-45	Closed	-$6K	–	126
2022 Q1	$6K	Buy	+45	New	+$5.4K	﹤0.01%	333

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DeDora Capital's AZN Position: Q2 2026 in Review

DeDora Capital reduced its AstraZeneca (AZN) stake by 0.31% in Q2 2026, selling an estimated $1.32K and leaving 2,226 shares worth $422K. The position accounts for 0.09% of the portfolio, ranked #91.

DeDora Capital first reported a position in AZN in Q1 2022 and has held it in 7 quarters since. The position peaked at $440K in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

DeDora Capital held 2,226 shares of AstraZeneca worth $422K as of Q2 2026.
DeDora Capital sold 7 AstraZeneca shares in Q2 2026, an estimated $1.32K.
AstraZeneca made up 0.09% of DeDora Capital's portfolio in Q2 2026, its #91 holding.
DeDora Capital first reported a position in AstraZeneca in Q1 2022 and has held it in 7 quarters since.
DeDora Capital's AstraZeneca position peaked at $440K in Q1 2026.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on DeDora Capital's 13F filing for Q2 2026, filed 13 Jul 2026.